I 

118TH CONGRESS 

2D SESSION H. R. 9598 

To amend the Office of National Drug Control Policy Reauthorization Act 

to reauthorize such Office, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 16, 2024 

Mr. COMER (for himself, Mr. RASKIN, Mr. DUARTE, Mr. NADLER, Mrs. 

GONZA ́LEZ-COLO ́N, and Ms. PLASKETT) introduced the following bill; 

which was referred to the Committee on Oversight and Accountability, 

and in addition to the Committees on the Judiciary, and Energy and 

Commerce, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Office of National 

5 Drug Control Policy Reauthorization Act of 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 9598 IH

1 SEC. 2. OFFICE OF NATIONAL DRUG CONTROL POLICY RE2 AUTHORIZATION. 

3 (a) AMENDMENTS TO THE OFFICE OF NATIONAL

4 DRUG CONTROL POLICY REAUTHORIZATION ACT OF

5 1998.—The Office of National Drug Control Policy Reau6 thorization Act of 1998 (21 U.S.C. 1701 et seq.) is 

7 amended— 

8 (1) in section 702 (21 U.S.C. 1701)— 

9 (A) in paragraph (2)(A)(ii), by striking 

10 ‘‘Government Reform’’ and inserting ‘‘Account11 ability’’; 

12 (B) in paragraph (3)— 

13 (i) in subparagraph (L), by striking ‘‘; 

14 and’’ and inserting a semicolon; 

15 (ii) in subparagraph (M), by striking 

16 the period at the end and inserting ‘‘; 

17 and’’; and 

18 (iii) by adding at the end the fol19 lowing: 

20 ‘‘(N) tertiary prevention support or serv21 ices, including opioid antagonists or overdose 

22 reversal agents such as naloxone, and other 

23 harm reduction activities such as overdose and 

24 drug detection testing.’’; 

25 (C) by amending paragraph (7) to read as 

26 follows:; 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 9598 IH

1 ‘‘(7) EMERGING DRUG THREAT.—The term 

2 ‘emerging drug threat’ means the occurrence of a 

3 new and growing trend in the illicit use or misuse 

4 of a drug, class of drugs, or non-controlled sub5 stance, or a new or evolving method of drug con6 sumption or trafficking, including rapid expansion in 

7 the supply of or demand for such a drug or sub8 stance.’’; 

9 (D) in paragraph (9), by striking ‘‘drug 

10 laws’’ and inserting the following: ‘‘drug, trade, 

11 and illicit drug trafficking laws’’; 

12 (E) in paragraph (10), by inserting after 

13 ‘‘demand reduction,’’ the following: ‘‘illicit drug 

14 trafficking,’’; 

15 (F) by redesignating paragraphs (15), 

16 (16), and (17) as paragraphs (17), (18), and 

17 (19), respectively; 

18 (G) by inserting after paragraph (14) the 

19 following new paragraph: 

20 ‘‘(15) PRECURSOR CHEMICAL.— 

21 ‘‘(A) IN GENERAL.—The term ‘precursor 

22 chemical’ includes a listed chemical and an un23 regulated precursor. 

24 ‘‘(B) LISTED CHEMICAL.—The term ‘listed 

25 chemical’ has the meaning given that term in 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 9598 IH

1 section 102 of the Controlled Substances Act 

2 (21 U.S.C. 802). 

3 ‘‘(C) UNREGULATED PRECURSOR.—The 

4 term ‘unregulated precursor’— 

5 ‘‘(i) means any chemical used in the 

6 production of illicit drugs that has not 

7 been identified as a listed chemical under 

8 the Controlled Substances Act; and 

9 ‘‘(ii) does not include a solvent or rea10 gent. 

11 ‘‘(16) STATE.—The term ‘State’ means each of 

12 the several States of the United States, the District 

13 of Columbia, and each territory or possession of the 

14 United States.’’; 

15 (H) in paragraph (19), as so redesig16 nated— 

17 (i) by redesignating subparagraphs 

18 (G) and (H) as subparagraphs (H) and 

19 (I), respectively; and 

20 (ii) by inserting after subparagraph 

21 (F) the following: 

22 ‘‘(G) activities to map, track, dismantle, 

23 and disrupt the financial enablers of drug traf24 ficking organizations, transnational criminal or25 ganizations, and money launderers involved in 


ssavage on LAPJG3WLY3PROD with BILLS
5 

•HR 9598 IH

1 the manufacture and trafficking of drugs in the 

2 United States and in foreign countries;’’; and 

3 (I) by inserting at the end the following: 

4 ‘‘(20) UNITED STATES.—The term ‘United 

5 States’, when used in a geographical sense, means 

6 all of the States, the District of Columbia, and the 

7 territories and possessions of the United States, and 

8 any waters within the jurisdiction of the United 

9 States. 

10 ‘‘(21) EVIDENCE.—The term ‘evidence’ has the 

11 meaning given that term in section 3561 of title 44, 

12 United States Code.’’; 

13 (2) in section 703(d) (21 U.S.C. 1702(d))— 

14 (A) in paragraph (5)(B), by striking ‘‘ac15 cepted by a contractor to be used in its per16 formance of a contract for the Office’’ and in17 serting the following: ‘‘accepted— 

18 ‘‘(i) by a contractor (or subcontractor 

19 thereof at any tier) for use in its perform20 ance of a contract for the Office; or 

21 ‘‘(ii) by a grant recipient (or sub22 grantee thereof at any tier) for use in car23 rying out an award related to a fund ad24 ministered by the Office.’’; and 


ssavage on LAPJG3WLY3PROD with BILLS
6 

•HR 9598 IH

1 (B) in paragraph (6), by inserting after 

2 ‘‘paragraph (5)’’ the following: ‘‘and the reg3 istry shall be sent to the appropriate Congres4 sional committees’’; 

5 (3) in section 704 (21 U.S.C. 1703)— 

6 (A) in subsection (a)(1)(C), by striking 

7 ‘‘shall’’ and inserting ‘‘may’’; 

8 (B) in subsection (b)— 

9 (i) in paragraph (16), by inserting 

10 after ‘‘to treat addiction’’ the following: ‘‘, 

11 encourage primary substance use preven12 tion, and increase accessibility and effec13 tiveness of life-saving opioid antagonists or 

14 reversal agents, such as naloxone’’; 

15 (ii) by striking paragraph (20); 

16 (iii) by redesignating paragraph (21) 

17 as paragraph (20); 

18 (iv) in paragraph (20), as so redesig19 nated, by striking the period at the end 

20 and inserting ‘‘; and’’; and 

21 (v) by inserting at the end the fol22 lowing: 

23 ‘‘(21) shall coordinate with the Secretary of 

24 Homeland Security, the Attorney General, and the 

25 Secretary of State regarding the status of the enVerDate Sep 11 2014 22:16 Sep 24, 2024 Jkt 049200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H9598.IH H9598

ssavage on LAPJG3WLY3PROD with BILLS
7 

•HR 9598 IH

1 forcement of clauses (i) and (ii) of subparagraph (A) 

2 and subparagraph (B) of section 237(a)(2) (8 

3 U.S.C. 1227(a)(2)) and subparagraphs (A) and (C) 

4 of section 212(a)(2) (8 U.S.C. 1182(a)(2)) for the 

5 purposes of ensuring such drug control and illicit 

6 drug trafficking enforcement activities are ade7 quately resourced.’’; 

8 (C) in subsection (c)— 

9 (i) in paragraph (1)(C), by striking 

10 ‘‘supply reduction, and State, local, and 

11 tribal affairs, including any drug law en12 forcement activities’’ and inserting the fol13 lowing: ‘‘supply reduction, accessibility to 

14 life-saving opioid antagonists or reversal 

15 agents, such as naloxone, and State, local, 

16 and Tribal affairs, including any drug re17 lated law enforcement activities’’; 

18 (ii) in paragraph (3)(C)— 

19 (I) in clause (ii), by inserting 

20 after ‘‘United States’’ the following: ‘‘, 

21 including at and between the ports of 

22 entry,’’; 

23 (II) in clause (iii), by striking ‘‘; 

24 and’’ and inserting a semicolon; 


ssavage on LAPJG3WLY3PROD with BILLS
8 

•HR 9598 IH

1 (III) in clause (iv), by striking 

2 the period at the end and inserting ‘‘; 

3 and’’; and 

4 (IV) by inserting at the end the 

5 following new clause: 

6 ‘‘(v) requests funding for activities 

7 that facilitate illicit drug use, but not in8 cluding overdose reversal medications, drug 

9 checking, or testing technology.’’; 

10 (D) in subsection (d)(8)(F)(ii), by striking 

11 ‘‘and at United States ports of entry by officers 

12 and employees of National Drug Control Pro13 gram agencies and domestic and foreign law en14 forcement officers’’ and inserting the following: 

15 ‘‘and at and between United States ports of 

16 entry by officers and employees of National 

17 Drug Control Program agencies and domestic 

18 and foreign law enforcement officers’’; 

19 (E) in subsection (i)— 

20 (i) in paragraph (1)(A), by striking 

21 ‘‘to address illicit drug use issues’’ and in22 serting the following: ‘‘to address illicit 

23 drug use, prevention and treatment of 

24 overdose and addiction, and law enforce25 ment activities’’; and 


ssavage on LAPJG3WLY3PROD with BILLS
9 

•HR 9598 IH

1 (ii) in paragraph (2), by striking 

2 ‘‘2023’’ and inserting ‘‘2031’’; and 

3 (F) in subsection (k)— 

4 (i) in the heading, by striking ‘‘HARM

5 REDUCTION PROGRAMS’’ and inserting 

6 ‘‘SUBSTANCE USE PREVENTION, HARM

7 REDUCTION, AND LIFE-SAVING TREAT8 MENT PROGRAMS’’; and 

9 (ii) in the first sentence, by inserting 

10 after ‘‘drug addiction and use’’ the fol11 lowing: ‘‘with the primary goal being the 

12 prevention of initial or continued use and 

13 the fostering of life-saving opioid antago14 nists or reversal agents, such as naloxone’’; 

15 (4) in section 705 (21 U.S.C. 1704)— 

16 (A) in subsection (a)(3)— 

17 (i) in subparagraph (A), by inserting 

18 after ‘‘Federal Government’’ the following: 

19 ‘‘and such lands owned by a foreign prin20 cipal (as such term in defined in section 

21 1(b) of the Foreign Agents Registration 

22 Act of 1938 (22 U.S.C. 611))’’; 

23 (ii) in subparagraph (B)— 

24 (I) by inserting after ‘‘the pre25 ceding year’’ the following: ‘‘, along 


ssavage on LAPJG3WLY3PROD with BILLS
10 

•HR 9598 IH

1 with historical comparisons over the 

2 prior 20 years,’’; 

3 (II) in clause (i)— 

4 (aa) by inserting after ‘‘seiz5 ing drugs,’’ the following: ‘‘in6 cluding precursor chemicals,’’; 

7 and 

8 (bb) by striking ‘‘; and’’ and 

9 inserting a semicolon; 

10 (III) in clause (ii), by striking 

11 the period at the end and inserting ‘‘; 

12 and’’; and 

13 (IV) by inserting at the end the 

14 following new clause: 

15 ‘‘(iii) the effects of trends of encoun16 ters of inadmissible aliens at and between 

17 the ports of entry, and the effect of any in18 creases or changes in the level of trade and 

19 travel, on the capacity and ability of the 

20 Department of Homeland Security compo21 nents to interdict and prevent the unlawful 

22 entry of illicit drugs into the United States 

23 by any means.’’; and 

24 (iii) in subparagraph (D)— 


ssavage on LAPJG3WLY3PROD with BILLS
11 

•HR 9598 IH

1 (I) by inserting after ‘‘the pre2 ceding year’’ the following: ‘‘, along 

3 with historical comparisons over the 

4 prior 20 years,’’; and 

5 (II) in clause (iii), by inserting 

6 after ‘‘seizing drugs,’’ the following: 

7 ‘‘including precursor chemicals,’’; 

8 (B) in subsection (e)(2), by inserting be9 fore the period at the end the following: ‘‘and 

10 $3,000,000 for each of fiscal years 2025 

11 through 2031’’; and 

12 (C) in subsection (f)— 

13 (i) in paragraph (2), by inserting after 

14 ‘‘agency shall’’ the following: ‘‘, in accord15 ance with guidelines issued by the Director 

16 for standard definitions, identification, and 

17 review procedures,’’; and 

18 (ii) by striking paragraph (4); 

19 (5) in section 706 (21 U.S.C. 1705)— 

20 (A) in subsection (c)— 

21 (i) in paragraph (1)— 

22 (I) by striking subparagraph (D); 

23 (II) in subparagraph (H)— 


ssavage on LAPJG3WLY3PROD with BILLS
12 

•HR 9598 IH

1 (aa) by inserting after 

2 ‘‘identifying existing’’ the fol3 lowing: ‘‘evidence,’’; and 

4 (bb) by striking ‘‘will obtain 

5 such data’’ and inserting ‘‘will 

6 ensure such data is obtained’’; 

7 (III) in subparagraph (J)(ii), by 

8 inserting ‘‘evidence,’’ before ‘‘data’’; 

9 (IV) in subparagraph (L), by in10 serting ‘‘evidence’’ after ‘‘Such other’’; 

11 and 

12 (V) in subparagraph (M)(iv), by 

13 inserting ‘‘storing and retrieving,’’ 

14 after ‘‘collecting,’’; 

15 (ii) in paragraph (2)— 

16 (I) by redesignating subpara17 graphs (E) and (F) as subparagraphs 

18 (G) and (H), respectively; and 

19 (II) by inserting after subpara20 graph (D) the following new subpara21 graphs: 

22 ‘‘(E) The Administrator of the Office of 

23 Information and Regulatory Affairs. 

24 ‘‘(F) The Chief Data Officers Council.’’; 

25 (iii) in paragraph (3)— 


ssavage on LAPJG3WLY3PROD with BILLS
13 

•HR 9598 IH

1 (I) in subparagraph (B)(ii)— 

2 (aa) in subclause (I), by 

3 striking ‘‘; and’’; 

4 (bb) in subclause (II), by 

5 striking the period at the end 

6 and inserting ‘‘; and’’; and 

7 (cc) by inserting at the end 

8 the following new subclause: 

9 ‘‘(III) an analysis of the effects 

10 of trends of encounters of inadmis11 sible aliens at and between the ports 

12 of entry, and the effect of any in13 creases or changes in the level of 

14 trade and travel, on the capacity and 

15 ability of the Department of Home16 land Security to interdict and prevent 

17 the unlawful entry of illicit drugs into 

18 the United States by any means.’’; 

19 and 

20 (II) by adding at the end the fol21 lowing new subparagraph: 

22 ‘‘(D) REQUIREMENT FOR CARIBBEAN BOR23 DER COUNTERNARCOTICS STRATEGY.— 

24 ‘‘(i) PURPOSES.—The Caribbean Bor25 der Counternarcotics Strategy shall— 


ssavage on LAPJG3WLY3PROD with BILLS
14 

•HR 9598 IH

1 ‘‘(I) set forth the strategy of the 

2 Federal Government for preventing 

3 the illegal trafficking of drugs through 

4 the Caribbean region into the United 

5 States, including through ports of 

6 entry, between ports of entry, and 

7 across air and maritime approaches; 

8 ‘‘(II) state the specific roles and 

9 responsibilities of each relevant Na10 tional Drug Control Program agency 

11 for implementing the strategy; 

12 ‘‘(III) identify the specific re13 sources required to enable the relevant 

14 National Drug Control Program agen15 cies to implement the strategy, to the 

16 extent practicable; and 

17 ‘‘(IV) be designed to promote, 

18 and not hinder, legitimate trade and 

19 travel. 

20 ‘‘(ii) SPECIFIC CONTENT RELATED TO

21 PUERTO RICO AND THE UNITED STATES

22 VIRGIN ISLANDS.—The Caribbean Border 

23 Counternarcotics Strategy shall include— 

24 ‘‘(I) a strategy to prevent the il25 legal trafficking of drugs to or 


ssavage on LAPJG3WLY3PROD with BILLS
15 

•HR 9598 IH

1 through Puerto Rico and the United 

2 States Virgin Islands, including meas3 ures to substantially reduce drug-re4 lated violent crime on such islands; 

5 and 

6 ‘‘(II) recommendations for addi7 tional assistance or authorities, if any, 

8 needed by Federal, State, and local 

9 law enforcement agencies relating to 

10 the strategy, including an evaluation 

11 of Federal technical and financial as12 sistance, infrastructure capacity build13 ing, and interoperability deficiencies.’’; 

14 and 

15 (iv) in paragraph (5), by striking 

16 ‘‘data’’ each place it appears and inserting 

17 ‘‘evidence, data,’’; 

18 (B) in subsection (f)— 

19 (i) in paragraph (1), by striking ‘‘pub20 licly available in a machine-readable for21 mat’’ and inserting the following: ‘‘publicly 

22 available as an open Government data 

23 asset (as such term is defined in section 

24 3502 of title 44, United States Code)’’; 


ssavage on LAPJG3WLY3PROD with BILLS
16 

•HR 9598 IH

1 (ii) in paragraph (2), by inserting 

2 after ‘‘searchable format’’ the following: 

3 ‘‘available for bulk download to the extent 

4 practicable’’; and 

5 (iii) by amending paragraph (3) to 

6 read as follows: 

7 ‘‘(3) DATA.—The data included in the Drug 

8 Control Data Dashboard shall be updated annually 

9 with final data, and to the extent practicable, up10 dated quarterly with provisional data, that aligns 

11 with the goals of the performance measurement sys12 tem required under subsection (h) and include, at a 

13 minimum, the following: 

14 ‘‘(A) For each substance identified by the 

15 Director as having a significant impact on illicit 

16 drug use in the United States, data sufficient 

17 to— 

18 ‘‘(i) assess supply reduction efforts, 

19 including, to the extent practicable, the 

20 total amount of substances seized; 

21 ‘‘(ii) assess drug use behaviors; 

22 ‘‘(iii) estimate the prevalence of sub23 stance use disorders; 

24 ‘‘(iv) show the number of fatal and 

25 non-fatal overdoses; and 


ssavage on LAPJG3WLY3PROD with BILLS
17 

•HR 9598 IH

1 ‘‘(v) assess the provision of substance 

2 use disorder treatment. 

3 ‘‘(B) Any quantifiable measures the Direc4 tor determines to be appropriate to detail 

5 progress toward the achievement of the goals of 

6 the National Drug Control Strategy, including, 

7 to the extent practicable, data disaggregated by 

8 specific geographic areas or sub-populations of 

9 interest. 

10 ‘‘(C) Data sufficient to assess the effective11 ness of such substance use disorder treatments. 

12 ‘‘(D) To the extent practicable, data suffi13 cient to show the extent of prescription drug di14 version, trafficking, and misuse in the calendar 

15 year and each of the previous 3 calendar years. 

16 ‘‘(E) Any quantifiable measures the Direc17 tor determines to be appropriate to detail 

18 progress toward the achievement of the goals of 

19 the National Drug Control Strategy, including 

20 to the extent practicable, data disaggregated by 

21 specific geographic areas or sub-populations of 

22 interest.’’; and 

23 (C) in subsection (g)(2)— 

24 (i) in subparagraph (D), by striking 

25 ‘‘narcotics’’ and inserting ‘‘drugs’’; 


ssavage on LAPJG3WLY3PROD with BILLS
18 

•HR 9598 IH

1 (ii) in subparagraph (E), by striking 

2 ‘‘drug use’’ and inserting ‘‘illegal drug 

3 use’’; and 

4 (iii) in subparagraph (F), by striking 

5 ‘‘drug use’’ and inserting ‘‘illegal drug 

6 use’’; 

7 (6) in section 707 (21 U.S.C. 1706)— 

8 (A) in subsection (l)(2)(F), by inserting 

9 ‘‘and authorities enforcing illicit drug traf10 ficking laws’’ after ‘‘task forces’’; 

11 (B) in subsection (m)(2), by inserting ‘‘, 

12 authorities enforcing illicit drug trafficking 

13 laws,’’ after ‘‘agencies’’; 

14 (C) in subsection (p)— 

15 (i) in paragraph (5). by striking ‘‘; 

16 and’’ and inserting a semicolon; 

17 (ii) in paragraph (6), by striking the 

18 period at the end and inserting ‘‘; and’’; 

19 and 

20 (iii) by inserting at the end the fol21 lowing new paragraph: 

22 ‘‘(7) $298,579,000 for each of fiscal years 2025 

23 through 2031.’’; 

24 (D) in subsection (s)— 


ssavage on LAPJG3WLY3PROD with BILLS
19 

•HR 9598 IH

1 (i) in the matter before paragraph 

2 (1), by striking ‘‘The Director’’ and insert3 ing ‘‘Except as provided in subsection 

4 (t)(2), the Director’’; 

5 (ii) in paragraph (2), by striking ‘‘; 

6 and’’ and inserting a semicolon; 

7 (iii) in paragraph (3), by striking the 

8 period at the end and inserting ‘‘; and’’; 

9 and 

10 (iv) by adding at the end the fol11 lowing: 

12 ‘‘(4) enhancing fentanyl seizure and interdiction 

13 activities.’’; and 

14 (E) by adding at the end the following: 

15 ‘‘(t) SUPPLEMENTAL GRANTS FOR FENTANYL

16 INTERDICTION ACTIVITIES.— 

17 ‘‘(1) MINIMUM ALLOCATION OF FUNDS FOR

18 FENTANYL INTERDICTION ACTIVITIES.—Of the 

19 amounts allocated for grants under subsection (s), 

20 not less than $5,000,000 shall be allocated for the 

21 purpose of making grants under subsection (s)(4). 

22 ‘‘(2) ADDITIONAL FUNDS.—In addition to 

23 amounts allocated under subparagraph (A) for the 

24 purpose of making grants under subsection (s)(4), 


ssavage on LAPJG3WLY3PROD with BILLS
20 

•HR 9598 IH

1 the Director may use amounts otherwise appro2 priated to carry out this section for such purpose. 

3 ‘‘(u) ADDITIONAL JUDICIARY PROSECUTORIAL RE4 SOURCES.— 

5 ‘‘(1) TEMPORARY REASSIGNMENT OF ASSIST6 ANT UNITED STATES ATTORNEYS.— 

7 ‘‘(A) AUTHORITY.—The Attorney General 

8 may identify assistant United States attorneys 

9 who may be made available for temporary reas10 signment under subsection (b)(2) for a period 

11 of time determined by the Attorney General in 

12 coordination with the Director, during which an 

13 assistant United States attorney shall prioritize 

14 the investigation and prosecution of organiza15 tions and individuals trafficking in fentanyl or 

16 fentanyl analogues. 

17 ‘‘(B) EXTENSION OF REASSIGNMENT.— 

18 Such reassignment may be extended by the At19 torney General for such time as may be nec20 essary to conclude any ongoing investigation or 

21 prosecution in which the assistant United 

22 States attorney is engaged. 

23 ‘‘(2) PROCESS FOR TEMPORARY REASSIGN24 MENT.—The Attorney General may establish a proc25 ess under which the Director, in consultation with 


ssavage on LAPJG3WLY3PROD with BILLS
21 

•HR 9598 IH

1 the Executive Boards of each designated high inten2 sity drug trafficking area, may request such an as3 sistant United States attorney to be so temporarily 

4 reassigned. 

5 ‘‘(v) USE OF FUNDS TO COMBAT FENTANYL TRAF6 FICKING.— 

7 ‘‘(1) REQUIREMENT.—As part of the docu8 mentation that supports the President’s annual 

9 budget request for the Office, the Director shall sub10 mit to Congress a report describing the use of 

11 HIDTA funds for the purposes of enhancing 

12 fentanyl seizure and interdiction activities under 

13 subsection (s)(4) or (t) and to investigate and pros14 ecute organizations and individuals trafficking in 

15 fentanyl or fentanyl analogues in the prior calendar 

16 year. 

17 ‘‘(2) CONTENTS.—The report shall include— 

18 ‘‘(A) the amounts of fentanyl or fentanyl 

19 analogues seized by HIDTA-funded initiative in 

20 the area during the previous year; and 

21 ‘‘(B) law enforcement intelligence and pre22 dictive data from the Drug Enforcement Ad23 ministration showing patterns and trends in 

24 abuse, trafficking, and transportation in 

25 fentanyl and fentanyl analogues. 


ssavage on LAPJG3WLY3PROD with BILLS
22 

•HR 9598 IH

1 ‘‘(w) REPORT ON DATA ANALYTICAL SERVICES PRO2 GRAM.— 

3 ‘‘(1) REPORT.—With respect to the Data Ana4 lytical Services program (formally known as Hemi5 sphere), and any successor program, the Director 

6 shall submit to the Committee on Oversight and Ac7 countability and the Committee on the Judiciary of 

8 the House of Representatives, and the Committee on 

9 the Judiciary of the Senate a report every two years 

10 on any activities of the program— 

11 ‘‘(A) funded by the Office; and 

12 ‘‘(B) carried out in two years prior to the 

13 submission of the report. 

14 ‘‘(2) CONTENTS OF REPORT.—The report re15 quired by paragraph (1) shall include the following: 

16 ‘‘(A) A documentation of any activities of 

17 the Data Analytical Services program, includ18 ing— 

19 ‘‘(i) the amount of searches conducted 

20 for each HIDTA; and 

21 ‘‘(ii) each requesting local law enforce22 ment jurisdiction. 

23 ‘‘(B) Information on how the program was 

24 funded and how funds were expended under the 

25 program, including information on any— 


ssavage on LAPJG3WLY3PROD with BILLS
23 

•HR 9598 IH

1 ‘‘(i) funding sources derived from 

2 each HIDTA’s funding allocation for a 

3 HIDTA, or any other source of funding, 

4 for the program; and 

5 ‘‘(ii) payments made by the program 

6 to any non-governmental entity or external 

7 vendor. 

8 ‘‘(C) A description of any policies and 

9 guidelines provided to HIDTA personnel and 

10 local law enforcement jurisdictions governing 

11 the operation of the program in order to ensure 

12 that such program does not infringe on rights 

13 protected under the Fourth Amendment or vio14 late legally protected privacy of United States 

15 citizens or individuals legally in the United 

16 States, along with any recommendations by the 

17 Director to strengthen such policies and guide18 lines.’’; 

19 (7) in section 709(f)(1) (21 U.S.C. 1708(f)(1)), 

20 by striking ‘‘shall’’ and inserting ‘‘may’’; 

21 (8) in section 709 (21 U.S.C. 1708)— 

22 (A) in subsection (f)(2)(B)(iii), by insert23 ing after ‘‘professionals’’ the following: ‘‘includ24 ing experts in evidence-based media campaigns, 

25 education, and evaluation’’; and 


ssavage on LAPJG3WLY3PROD with BILLS
24 

•HR 9598 IH

1 (B) in subsection (g), by striking ‘‘2023’’ 

2 and inserting ‘‘2031’’; 

3 (9) in section 711 (21 U.S.C. 1710), including 

4 the headings, by striking ‘‘Command and Control 

5 Plan’’ each place it appears and inserting ‘‘Strategic 

6 Plan’’; and 

7 (10) in section 714 (21 U.S.C. 1711), by insert8 ing before the period at the end the following: ‘‘and 

9 $20,000,000 for each of fiscal years 2025 through 

10 2031’’. 

11 (b) AMENDMENTS TO THE ANTI-DRUG ABUSE ACT

12 OF 1988.—The Anti-Drug Abuse Act of 1988 (Public Law 

13 100–690) is amended— 

14 (1) in section 1024(a) (21 U.S.C. 1524(a)), by 

15 inserting before the period at the end the following: 

16 ‘‘and $109,000,000 for each of fiscal years 2025 

17 through 2031’’; and 

18 (2) in section 1032(b) (21 U.S.C. 1532(b))— 

19 (A) by striking ‘‘$125,000’’ each place the 

20 term appears and inserting ‘‘$150,000’’; and 

21 (B) in paragraph (3)— 

22 (i) by striking subparagraph (A) and 

23 inserting the following: 

24 ‘‘(A) IN GENERAL.—Subject to subpara25 graph (F), the Administrator may award up to 


ssavage on LAPJG3WLY3PROD with BILLS
25 

•HR 9598 IH

1 2 additional grants under this paragraph to an 

2 eligible coalition awarded a grant under para3 graph (1) or (2) for any first fiscal year after 

4 the end of the 4-year or 9-year period following 

5 the period of the initial or subsequent grant 

6 under paragraph (1) or (2), as the case may 

7 be.’’; 

8 (ii) in subparagraph (B), by striking 

9 ‘‘a renewal grant’’ and inserting ‘‘up to 2 

10 renewal grants’’; 

11 (iii) in subparagraph (C), by striking 

12 ‘‘an additional grant’’ and inserting ‘‘the 

13 additional grants’’; and 

14 (iv) by striking subparagraph (D) and 

15 inserting the following: 

16 ‘‘(D) RENEWAL GRANTS.—Subject to sub17 paragraph (F), the Administrator may award a 

18 renewal grant to a grant recipient under this 

19 paragraph for each fiscal year of the 4-fiscal20 year period following the first fiscal year for 

21 which an additional grant under this paragraph 

22 is awarded in an amount not to exceed the 

23 amount of non-Federal funds raised by the coa24 lition, including in-kind contributions, for that 

25 fiscal year.’’. 


ssavage on LAPJG3WLY3PROD with BILLS
26 

•HR 9598 IH

1 (c) REAUTHORIZATION OF THE NATIONAL COMMU2 NITY ANTI-DRUG COALITION INSTITUTE.—Section 4(d) 

3 of Public Law 107–82 (21 U.S.C. 1521 note) is amended 

4 by striking ‘‘section 1032 of the National Narcotics Lead5 ership Act of 1988 (15 U.S.C. 1532), make a grant of 

6 $2 million under subsection (a), for each of the fiscal years 

7 2018 through 2023’’ and inserting ‘‘section 1024 of the 

8 National Narcotics Leadership Act of 1988 (21 U.S.C. 

9 1524), make a grant of $2,500,000 under subsection (a), 

10 for each of the fiscal years 2025 through 2031’’. 

11 (d) REAUTHORIZATION OF COMMUNITY-BASED COA12 LITION ENHANCEMENT GRANTS TO ADDRESS LOCAL

13 DRUG CRISES.—Subsection (i) of section 103 of the Com14 prehensive Addiction and Recovery Act of 2016 (21 U.S.C. 

15 1536) is amended by inserting before the period at the 

16 end the following: ‘‘and $5,200,000 for each of fiscal years 

17 2025 through 2031’’. 

18 (e) REPORT REGARDING LIFE-SAVING OPIOID AN19 TAGONISTS OR REVERSAL AGENTS.—The Office of Na20 tional Drug Control Policy Reauthorization Act of 2006 

21 (Public Law 109–469) is amended by adding at the end 

22 the following new section: 


ssavage on LAPJG3WLY3PROD with BILLS
27 

•HR 9598 IH

1 ‘‘SEC. 1121. REQUIREMENT FOR LIFE-SAVING OPIOID OVER2 DOSE REVERSAL STUDY. 

3 ‘‘(a) FINDING.—Congress finds that it is vital to sup4 port access to treatment and emergency intervention tools 

5 to address drug addiction while also pursuing strategies 

6 to ensure communities have readily available access to life7 saving drug overdose reversal medications, including 

8 opioid antagonists or reversal agents, such as naloxone, 

9 in case of an emergency. 

10 ‘‘(b) REPORT.—Not later than 180 days after the 

11 date of the enactment of this section, the Director of the 

12 Office of National Drug Control Policy shall submit to 

13 Congress a report that contains the following: 

14 ‘‘(1) A summary of the relevant roles, respon15 sibilities, and authorities of each relevant National 

16 Drug Control Program agency to ensure that life17 saving drug overdose reversal medications are read18 ily available in case of an emergency, including life19 saving opioid antagonists or reversal agents, such as 

20 naloxone, across the Nation. 

21 ‘‘(2) A strategy for the Federal Government to 

22 ensure that State, local, and Tribal governments, 

23 and agencies thereof including law enforcement and 

24 public health and safety entities, have life-saving 

25 drug overdose reversal medications readily available 

26 in case of an emergency, including life-saving opioid 


ssavage on LAPJG3WLY3PROD with BILLS
28 

•HR 9598 IH

1 antagonists or reversal agents, such as naloxone, 

2 which at a minimum identifies— 

3 ‘‘(A) any Federal and State policies and 

4 actions necessary for the relevant National 

5 Drug Control Program agencies to take to ad6 dress— 

7 ‘‘(i) the challenges faced by phar8 macists, prescription drug providers, dis9 pensers (including manufacturers, distribu10 tors, and retailers), and other health care 

11 providers, to make such medications read12 ily available to patients over the counter 

13 for emergency use; 

14 ‘‘(ii) the challenges faced by phar15 macists, health care providers, and State 

16 health officials to educate the public on the 

17 risks and benefits of such medications, in18 cluding how to effectively use such medica19 tions; and 

20 ‘‘(iii) the appropriate training of State 

21 and local health care providers and first 

22 responders on the use of such medications; 

23 and 

24 ‘‘(B) identifies any budgetary resources, 

25 personnel resources, licensing requirements, and 


ssavage on LAPJG3WLY3PROD with BILLS
29 

•HR 9598 IH

1 legal authorities that relevant National Drug 

2 Control Program agencies needs to enable the 

3 availability of such life-saving emergency drug 

4 overdose medications; 

5 ‘‘(3) A summary of policies in effect before the 

6 submission of the report that are administered by— 

7 ‘‘(A) the Director of the Office National 

8 Drug Control Policy; 

9 ‘‘(B) the Secretary of Health and Human 

10 Services; and 

11 ‘‘(C) each National Drug Control Program 

12 agency, as applicable. 

13 ‘‘(4) A summary of the specific actions taken 

14 over the previous 10 years before the submission of 

15 the report by the Substance Abuse and Mental 

16 Health Services Administration and the Drug En17 forcement Administration to coordinate with one an18 other and with State health agencies to ensure 

19 that— 

20 ‘‘(A) such treatments, including medica21 tions, are accessible to the public; and 

22 ‘‘(B) appropriate public education on the 

23 use of, and the risks and benefits of, such treat24 ments, including medications, are readily avail25 able. 


ssavage on LAPJG3WLY3PROD with BILLS
30 

•HR 9598 IH

1 ‘‘(c) UPDATES.—Any significant update made to the 

2 strategy included in the report required by paragraph 

3 (2)(B) after such report is submitted shall be included in 

4 the next National Drug Control Strategy submitted to 

5 Congress after such update is made.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS